Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): A randomised phase 3 study

The Lancet Oncology

Volumn 15, Issue 1, 2014, Pages 106-113

  Kubota, Kaoru ^a   Hida, Toyoaki ^b   Ishikura, Satoshi ^c   Mizusawa, Junki ^d   Nishio, Makoto ^e   Kawahara, Masaaki ^f   Yokoyama, Akira ^g   Imamura, Fumio ^h   Takeda, Koji ⁱ   Negoro, Shunichi ^j   Harada, Masao ^k   Okamoto, Hiroaki ^l   Yamamoto, Nobuyuki ^m   Shinkai, Tetsu ⁿ   Sakai, Hiroshi ^o   Matsui, Kaoru ^p   Nakagawa, Kazuhiko ^q   Shibata, Taro ^d   Saijo, Nagahiro ^r   Tamura, Tomohide ^d  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER CENTER   (Japan)

^e CANCER INSTITUTE HOSPITAL   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^g NIIGATA CANCER CENTER HOSPITAL   (Japan)

^h OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

ⁱ OSAKA CITY GENERAL HOSPITAL   (Japan)

^j HYOGO CANCER CENTER   (Japan)

^k HOKKAIDO CANCER CENTER   (Japan)

^l YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^m SHIZUOKA CANCER CENTER   (Japan)

ⁿ NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^o SAITAMA CANCER CENTER   (Japan)

^p Respiratory and Allergic Diseases   (Japan)

^q KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r Japanese Society of Medical Oncology   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IRINOTECAN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY WEIGHT DISORDER; BRAIN INFARCTION; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DYSPHAGIA; ESOPHAGITIS; FEBRILE NEUTROPENIA; FEVER; HUMAN; HYPOALBUMINEMIA; INFECTION; INTENTION TO TREAT ANALYSIS; JAPAN; LEUKOPENIA; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PHARYNGITIS; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

EID: 84891372333     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(13)70511-4     Document Type: Article

References (23)

1. Ito H, Tanaka H, Koestler DC, et al. Nonfilter and filter cigarette consumption and the incidence of lung cancer by histological type in Japan and the United States: analysis of 30-year data from population-based cancer registries. Int J Cancer 2011, 128:1918-1928.
2. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006, 24:4539-4544.
3. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992, 327:1618-1624.
4. Warde P, Payne D Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992, 10:890-895.
5. Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 1993, 11:336-344. The National Cancer Institute of Canada Clinical Trials Group.
6. Jeremic B, Shibamoto Y, Acimovic L, et al. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol 1997, 15:893-900.
7. Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002, 20:3054-3060.
8. Turrisi AT, Kyungman K, Blum R, et al. Twice daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999, 340:265-271.
9. Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002, 346:85-91.
10. Kubota K, Nishiwaki Y, Sugiura T, et al. Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903. Clin Cancer Res 2005, 11:5534-5538.
11. Sanuki-Fujimoto N, Ishikura S, Hayakawa K, et al. Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202. Radiat Oncol 2009, 4:16.
12. Lan KKG, DeMets DL Discrete sequential boundaries for clinical trials. Biometrika 1983, 70:659-663.
13. Lara PN, Natale R, Crowley J, et al. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol 2009, 27:2530-2535.
14. Hanna N, Bunn PA, Langer C, et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 2006, 24:2038-2043.
15. Zatloukal P, Cardenal F, Szczesna A, et al. A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease. Ann Oncol 2010, 21:1810-1816.
16. Lara PN, Chansky K, Shibata T, et al. Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology Group 0124. Cancer 2010, 116:5710-5715.
17. Jiang J, Liang X, Zhou X, et al. A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer. J Thorac Oncol 2010, 5:867-873.
18. Lima JP, dos Santos LV, Sasse EC, et al. Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer: systematic review with meta-analysis. J Thorac Oncol 2010, 5:1986-1993.
19. Ohri N, Shen Z, Dicker AP, et al. Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials. J Natl Cancer Inst 2013, 105:387-393.
20. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010, 363:733-742.
21. Temel JS, Greer JA, Admane S, et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol 2011, 29:2319-2326.
22. Yokoyama A, Kurita Y, Saijo N, et al. Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer. Br J Cancer 1998, 78:257-262.
23. Fox W, Scadding JG Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. Lancet 1973, 302:63-65.